YAKIMA, Wash., Jan. 24, 2016 -- The doctors at Washington Vision Therapy Center announced that changes in many major insurance plans now include coverage for vision therapy. Several Medicaid plans, including Coordinated Care Health, Molina Healthcare, and United Healthcare Healthy Options, have decided to provide coverage for neuro-visual rehabilitation, also known as vision therapy. Prior to this decision, many patients who needed vision therapy, but also required financial assistance for the program, have had to wait for services.
Dr. Benjamin Winters of Washington Vision Therapy Center is thrilled with the decision to provide more extensive coverage to those who may need it most. "Vision therapy can have a huge impact on the life of an individual who is in need of these services. Knowing that their treatment is now covered by Medicaid and most other insurers will provide a great level of ease and comfort to these clients," stated Dr. Winters. "When we begin a program of vision therapy with a patient, we like to sit down with the patient and his or her family. We outline the diagnosis and treatment needs as well as the coverage provided by their insurer. At that meeting we will have already looked into your insurance coverage. Our staff will work with any insurance provider whether it is Medicaid or a small provider to ensure that our patients get the benefits due to them. We believe it is just one sign of how our practice goes above and beyond to serve our clients."
Vision therapy addresses conditions such as convergence insufficiency (eye-teaming difficulties), accommodative dysfunction (eye-focusing problems), oculomotor dysfunction (difficulty with eye tracking), strabismus (wandering eye) and amblyopia ("lazy eye"). According to Dr. Winters, "We frequently see these issues in our practice. Patients rarely understand that their difficulty in academics or reading comprehension are due to vision issues. Sometimes patients, particularly the young, are incorrectly diagnosed and labeled with learning difficulties, when in reality their eyes are not working together well."
Vision therapy is an individualized course of treatment designed to address symptoms such as tired eyes and headaches associated with computer work and reading, blurring and doubling vision, and visual attention that are keeping a patient from reaching their full potential in life. Developmental optometrists and trained vision therapists use a variety of methods to improve vision including specialized lenses, prisms, and exercises. Appointments usually take around 1 hour each and are scheduled normally once a week. Patients may be given additional exercises to complete at home. Depending on the complexity of the patient's vision issues, therapy may take between 4 to 10 months or longer for severe conditions.
To make an appointment to discuss vision therapy for you or your child, contact Washington Vision Therapy Center at (509) 654-9256. Regular office hours are from 8:00 AM to 5:00 PM, Monday through Friday. For more information visit them online at www.wavtc.com.
Washington Vision Therapy Center, (509) 654-9256


Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 



